In 2006, the Beiersdorf Group again achieved record highs in sales and operating results (excluding special factors). The special factors include implementation expenses for the realignment of the Consumer Supply Chain and the income from the sale of BSN medical.
All figures are preliminary and not audited yet. The group financial statements as well as those of the Beiersdorf AG will be endorsed by the Executive Board beginning February and approved by the Supervisory Board end of February. The Annual Accounts Press Conference and the Financial Analyst Meeting will be held on March 1, 2007.
Group sales grew at current exchange rates by 7.2% to € 5,120 million (previous year: € 4,776 million). Adjusted for currency translation effects, this means an increase of 7.3%.
Operating result (EBIT) excluding special factors reached about € 590 million (previous year: € 531 million), EBIT margin was around 11.5%. Profit after tax excluding special factors amounted to approximately € 385 million (previous year: € 335 million). This corresponds to a net profit margin excluding special factors of approximately 7.5%. EBIT and profit after tax developed clearly better than sales.
In 2006, the Consumer business segment achieved sales growth of 7.1% at current exchange rates to € 4,327 million (previous year: € 4,041 million). Adjusted for currency translation effects, sales growth amounted to 7.2%. All regions contributed positive growth rates.
Double digit growth could be generated in the regions Eastern Europe, Latin America and Africa/Asia/Australia. Consumer EBIT excluding special factors reached about € 520 million (previous year: € 470 million), return on sales reached about 12.0%.